Gal-3 binds activated-committed CD8 T cells only in the tumor microenvironment and suppresses their anti-tumor response via Lymphocyte-activation gene (LAG)-3 and by inhibiting the expansion of plasmacytoid dendritic cells (42). This evidence concerns the gene LGALS3 and neoplasm.